Shanghai Haoyuan Chemexpress Co.Ltd(688131) board of directors
Description of assets purchased and sold within 12 months before this transaction
Shanghai Haoyuan Chemexpress Co.Ltd(688131) (hereinafter referred to as “the company”) intends to issue shares and pay cash to Wang Yuan (Wang Yuan), Shanghai Yuanmeng enterprise management consulting partnership (limited partnership), Qidong Yuanli enterprise management consulting partnership (limited partnership) and Ningbo Jiusheng innovative pharmaceutical technology Co., Ltd. to purchase 100% equity of YaoYuan pharmaceutical Chemistry (Shanghai) Co., Ltd, At the same time, it plans to issue shares to the controlling shareholder Shanghai Anshu Information Technology Co., Ltd. to raise supporting funds (hereinafter referred to as “this transaction”).
According to Article 14 of the measures for the administration of major asset restructuring of listed companies: “If a listed company purchases or sells the same or related assets continuously within 12 months, the corresponding amount shall be calculated based on the cumulative amount. The asset transaction that has prepared and disclosed the report on major asset restructuring in accordance with the provisions of these measures need not be included in the scope of cumulative calculation. The cumulative period of major asset restructuring stipulated by the CSRC in paragraph 1 of Article 13 of these measures If the limits and scope are otherwise specified, such provisions shall prevail. If the underlying assets of the transaction are owned or controlled by the same trading party, or belong to the same or similar business scope, or under other circumstances recognized by the China Securities Regulatory Commission, they can be recognized as the same or related assets. “
The company did not purchase or sell the same or related assets as the subject assets of this transaction within 12 months before this transaction.
It is hereby explained.
Shanghai Haoyuan Chemexpress Co.Ltd(688131) board of directors March 5, 2022
